BRCA|https://phgkb.cdc.gov/GAPPKB/phgHome.do|BRCA

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From HuGE Literature Finder Database

This database contains published literature on genetic associations and other human genome epidemiology

---

• A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study.  
  Annals of oncology : official journal of the European Society for Medical Oncology 2017 May 28 (5): 996-1004.
  Monk B J, Brady M F, Aghajanian C, Lankes H A, Rizack T, Leach J, Fowler J M, Higgins R, Hanjani P, Morgan M, Edwards R, Bradley W, Kolevska T, Foukas P, Swisher E M, Anderson K S, Gottardo R, Bryan J K, Newkirk M, Manjarrez K L, Mannel R S, Hershberg R M, Coukos
• Analysis Suggests Wider Use for PARP Inhibitors.  
  Cancer discovery 2017 Apr .
  Authors are not available
• Impact of primary platinum-free interval and BRCA1/2 mutation status on treatment and survival in patients with recurrent ovarian cancer.  
  Gynecologic oncology 2017 Apr .
  Bookman Michael A, Tyczynski Jerzy E, Espirito Janet L, Wilson Thomas W, Fernandes Ancilla
• Analysis of chromosomal radiosensitivity of healthy BRCA2 mutation carriers and non-carriers in BRCA families with the G2 micronucleus assay.  
  Oncology reports 2017 Mar 37 (3): 1379-1386.
  Baert Annelot, Depuydt Julie, Van Maerken Tom, Poppe Bruce, Malfait Fransiska, Van Damme Tim, De Nobele Sylvia, Perletti Gianpaolo, De Leeneer Kim, Claes Kathleen B M, Vral An
• Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.  
  Breast cancer research and treatment 2017 Mar .
  Krammer Julia, Pinker-Domenig Katja, Robson Mark E, Gönen Mithat, Bernard-Davila Blanca, Morris Elizabeth A, Mangino Debra A, Jochelson Maxine

more